Drug factory · FDA FEI 3007498452
Hangzhou Minsheng Binjiang Pharmaceutical Co.,Ltd
658 Bin'an Road Binjiang District, Hangzhou, China
Serious problems, FDA action at FDA's last inspection, Mar 7, 2025.
Official Action Indicated: inspectors found significant problems and FDA recommended regulatory action, such as a warning letter or import alert.
6 drug inspections on record since 2011: 2 with no problems, 3 with problems fixed voluntarily, 1 with FDA action.
What it does, for whom
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 7, 2025 | Serious problems, FDA action | Drug Quality Assurance | — |
| Sep 13, 2019 | No problems found | Drug Quality Assurance | — |
| May 11, 2018 | No problems found | Drug Quality Assurance | — |
| Jul 29, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Apr 25, 2014 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 10, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.